Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
3 studies found for:    18413705 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Terminated Multicentre Trial to Evaluate the Safety and Efficacy of CP-316,311 in Major Depressive Disorder
Condition: Depressive Disorder, Major
Interventions: Drug: CP-316,311;   Drug: Placebo;   Drug: Sertraline
2 Terminated Pexacerfont for Stress-induced Food Craving
Conditions: Daily Oral Pexacerfont for 28 Days (300 mg/Day Loading Dose for 7 Days, Followed;   Placebo
Intervention: Drug: Pexacerfont
3 Withdrawn Pexacerfont to Reduce Stress-induced Tobacco Craving
Condition: Nicotine Dependence

Study has passed its completion date and status has not been verified in more than two years.